1. Home
  2. PCRX vs NPKI Comparison

PCRX vs NPKI Comparison

Compare PCRX & NPKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • NPKI
  • Stock Information
  • Founded
  • PCRX 2006
  • NPKI 1932
  • Country
  • PCRX United States
  • NPKI United States
  • Employees
  • PCRX N/A
  • NPKI N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • NPKI Metal Fabrications
  • Sector
  • PCRX Health Care
  • NPKI Industrials
  • Exchange
  • PCRX Nasdaq
  • NPKI Nasdaq
  • Market Cap
  • PCRX 604.7M
  • NPKI 636.6M
  • IPO Year
  • PCRX 2011
  • NPKI N/A
  • Fundamental
  • Price
  • PCRX $21.88
  • NPKI $7.55
  • Analyst Decision
  • PCRX Buy
  • NPKI
  • Analyst Count
  • PCRX 10
  • NPKI 0
  • Target Price
  • PCRX $27.60
  • NPKI N/A
  • AVG Volume (30 Days)
  • PCRX 762.4K
  • NPKI 477.6K
  • Earning Date
  • PCRX 02-27-2025
  • NPKI 02-19-2025
  • Dividend Yield
  • PCRX N/A
  • NPKI N/A
  • EPS Growth
  • PCRX N/A
  • NPKI N/A
  • EPS
  • PCRX N/A
  • NPKI N/A
  • Revenue
  • PCRX $694,957,000.00
  • NPKI $748,372,000.00
  • Revenue This Year
  • PCRX $4.83
  • NPKI N/A
  • Revenue Next Year
  • PCRX $2.16
  • NPKI N/A
  • P/E Ratio
  • PCRX N/A
  • NPKI $19.22
  • Revenue Growth
  • PCRX 4.40
  • NPKI 93.70
  • 52 Week Low
  • PCRX $11.16
  • NPKI $5.61
  • 52 Week High
  • PCRX $34.01
  • NPKI $8.65
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 68.77
  • NPKI N/A
  • Support Level
  • PCRX $18.18
  • NPKI N/A
  • Resistance Level
  • PCRX $22.36
  • NPKI N/A
  • Average True Range (ATR)
  • PCRX 1.04
  • NPKI 0.00
  • MACD
  • PCRX 0.21
  • NPKI 0.00
  • Stochastic Oscillator
  • PCRX 88.54
  • NPKI 0.00

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About NPKI NPK International Inc. Common Stock

NPK International Inc Formerly Newpark Resources Inc is a diversified supplier providing environmentally-sensitive products, as well as rentals and services to customers across multiple industries. The company has two operating segments: Industrial Solutions and Fluids Systems. Fluids Systems segment which generates the majority of the revenue, provides drilling, completion, and stimulation fluids products and related technical services to customers for oil, natural gas, and geothermal projects. Geographically, the company derives majority of its revenue from the United States and also has its presence in Canada, EMEA, Latin America, and Asia Pacific regions.

Share on Social Networks: